Iterum Therapeutics
(ITRM)
undefined
undefined%
At close: undefined
2.03
2.78%
Pre-market Jan 07, 2025, 04:18 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 6.07M | 21.09M | 27.45M | 14.51M | 4.80M | 44.55M | 8.48M | 24.81M |
| Short-Term Investments | 17.86M | 39.75M | 53.94M | 2.36M | 1.14K | 40.00M | 30.73M | 404.00K |
| Long-Term Investments | n/a | -35.00K | 64.00K | 248.00K | 60.00K | 959.00K | n/a | n/a |
| Other Long-Term Assets | 63.00K | 4.21M | 6.64M | 17.61M | 20.32M | 11.54M | 1.84M | 1.05M |
| Receivables | 233.00K | n/a | 1.21M | 865.00K | 1.10M | 721.00K | 509.00K | 245.00K |
| Inventory | n/a | -1.85M | -3.13M | -3.74M | -8.03M | -7.87M | n/a | n/a |
| Other Current Assets | 1.43M | 1.09M | 717.00K | 6.04M | 5.81M | 8.63M | 4.45M | 404.00K |
| Total Current Assets | 25.60M | 60.84M | 81.34M | 14.51M | 4.80M | 84.67M | 44.17M | 25.86M |
| Property-Plant & Equipment | 600.00K | 69.00K | 91.00K | 421.00K | 572.00K | 700.00K | 747.00K | n/a |
| Goodwill & Intangibles | n/a | 1.72M | 3.44M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 663.00K | 6.00M | 10.16M | 18.28M | 20.95M | 13.20M | 2.58M | 1.05M |
| Total Assets | 26.26M | 66.83M | 91.51M | 32.79M | 25.75M | 97.87M | 46.76M | 26.92M |
| Account Payables | 5.00M | 2.77M | 878.00K | 816.00K | 15.49M | 4.04M | 3.15M | 1.48M |
| Deferred Revenue | n/a | -332.00K | -2.50M | -7.30M | 12.66M | 113.00K | n/a | n/a |
| Short-Term Debt | n/a | n/a | 1.63M | 6.49M | 5.80M | 1.02M | n/a | n/a |
| Other Current Liabilities | 8.52M | 6.29M | 10.21M | 34.29M | 15.50M | 7.05M | 3.97M | 2.74M |
| Total Current Liabilities | 13.52M | 196.00K | 6.06M | 28.86M | 36.99M | 12.22M | 7.13M | 4.22M |
| Long-Term Debt | 18.96M | 29.77M | 24.90M | 41.02M | 14.37M | 13.08M | n/a | n/a |
| Other Long-Term Liabilities | 188.00K | n/a | 3.44M | 630.00K | 630.00K | 951.00K | 137.00K | 30.00K |
| Total Long-Term Liabilities | 19.14M | 38.64M | 35.22M | 54.49M | 51.99M | 26.25M | 137.00K | 30.00K |
| Total Liabilities | 32.66M | 38.83M | 41.27M | 83.35M | 51.99M | 26.25M | 7.26M | 4.25M |
| Total Debt | 18.96M | 28.47M | 24.90M | 35.85M | 7.63M | 13.08M | n/a | n/a |
| Common Stock | 135.00K | 126.00K | 1.83M | 494.00K | 149.00K | 144.00K | 4.00K | 4.00K |
| Retained Earnings | -461.30M | -422.93M | -378.49M | -286.93M | -234.92M | -131.79M | -54.74M | -25.33M |
| Comprehensive Income | 1K | -350.00K | n/a | n/a | n/a | -201.00K | -65.00K | -0.00 |
| Shareholders Equity | -6.40M | 28.00M | 50.23M | -50.56M | -26.24M | 71.62M | 39.49M | 22.67M |
| Total Investments | 17.86M | 39.71M | 53.94M | 248.00K | 60.00K | 40.96M | 30.73M | 404.00K |